|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Hilsden RJ, Heitman SJ, Lamidi M, Diallo
MD, English J, Town S, Cartwright S, Maxwell C, McGillivray ME,
McGregor E, et al: Cohort profile: The Forzani & MacPhail colon
cancer screening centre biorepository, Calgary, Alberta. BMJ Open.
10:e0381192020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mochizuki K, Kudo SE, Kato K, Kudo K,
Ogawa Y, Kouyama Y, Takashina Y, Ichimasa K, Tobo T, Toshima T, et
al: Molecular and clinicopathological differences between depressed
and protruded T2 colorectal cancer. PLoS One. 17:e02735662022.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han B, Zheng R, Zeng H, Wang S, Sun K,
Chen R, Li L, Wei W and He J: Cancer incidence and mortality in
China, 2022. J Natl Cancer Cent. 4:47–53. 2024.PubMed/NCBI
|
|
5
|
Yan S, Wang W, Feng Z, Xue J, Liang W, Wu
X, Tan Z, Zhang X, Zhang S, Li X and Zhang C: Immune checkpoint
inhibitors in colorectal cancer: Limitation and challenges. Front
Immunol. 15:14035332024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang G, Zhang R, Yang X, Zhang W and Hou
Y: Positive correlation between miR-570 and prognosis of colon
cancer: Inhibition of cell proliferation and invasion. Clin Exp
Med. 22:193–200. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wathoni N, Nguyen AN, Rusdin A, Umar AK,
Mohammed AFA, Motoyama K, Joni IM and Muchtaridi M: Enteric-coated
strategies in colorectal cancer nanoparticle drug delivery system.
Drug Des Devel Ther. 14:4387–4405. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie J, Ye F, Deng X, Tang Y, Liang JY,
Huang X, Sun Y, Tang H, Lei J, Zheng S and Zou Y: Circular RNA: A
promising new star of vaccine. J Transl Int Med. 11:372–381. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xie Y, Xie J, Huang G, Zhang J, Song C,
Luo Y, Tang H, Tang Y, Xiao X, Zhang C, et al: Isoliquiritigenin
reduces brain metastasis by circNAV3-ST6GALNAC5-EGFR axis in
triple-negative breast cancer. Cancer Lett. 624:2177342025.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yi J, Li B, Yin X, Liu L, Song C, Zhao Y,
Cai M, Tang H, Chen D and Lyu N: CircMYBL2 facilitates
hepatocellular carcinoma progression by regulating E2F1 expression.
Oncol Res. 32:1129–1139. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang X, Ren H, Guo M, Qian J, Yang Y and
Gu C: Review on circular RNAs and new insights into their roles in
cancer. Comput Struct Biotechnol J. 19:910–928. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu F, Peng Y, Fan X, Zhang X and Jin Z:
Circular RNAs: Implications of signaling pathways and
bioinformatics in human cancer. Cancer Biol Med. 20:104–128. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee YJ, Kim WR, Park EG, Lee DH, Kim JM,
Shin HJ, Jeong HS, Roh HY and Kim HS: Exploring the key signaling
pathways and ncRNAs in colorectal cancer. Int J Mol Sci.
25:45482024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song J, Liu Q, Han L, Song T, Huang S,
Zhang X, He Q, Liang C, Zhu S and Xiong B:
Hsa_circ_0009092/miR-665/NLK signaling axis suppresses colorectal
cancer progression via recruiting TAMs in the tumor
microenvironment. J Exp Clin Cancer Res. 42:3192023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song W, Miao L, Zhang K, Liu Y, Lin J, Li
J, Huang Z, Cao D, Zhang Y and Hu C: Sevoflurane suppresses
colorectal cancer malignancy by modulating β-catenin ubiquitination
degradation via circSKA3. Cell Signal. 114:1109872024. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu X, Zhang Y, Yuan W, Han R, Zhong J,
Yang X, Zheng M and Xie B: Exosomal CircRNAs in circulation serve
as diagnostic biomarkers for acute myocardial infarction. Front
Biosci (Landmark Ed). 29:1492024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu Q, Jia Y, Liu Y, Wu B, Wang J, Ao X and
Ding W: Novel insights into the N 6-methyladenosine modification on
circRNA in cancer. Front Oncol. 15:15548882025. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Long BY, Wang Y, Hao SH and Shi G:
Molecular significance of circRNAs in malignant lymphoproliferative
disorders: Pathogenesis and novel biomarkers or therapeutic
targets. Am J Cancer Res. 14:4633–4651. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang C and Zhang B: RNA therapeutics:
Updates and future potential. Sci China Life Sci. 66:12–30. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu X, Zhang Y, Zhou S, Dain L, Mei L and
Zhu G: Circular RNA: An emerging frontier in RNA therapeutic
targets, RNA therapeutics, and mRNA vaccines. J Control Release.
348:84–94. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma Y, Liu Y and Jiang Z: CircRNAs: A new
perspective of biomarkers in the nervous system. Biomed
Pharmacother. 128:1102512020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jagtap U, Anderson ES and Slack FJ: The
emerging value of circular noncoding RNA research in cancer
diagnosis and treatment. Cancer Res. 83:809–813. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Q, Yang D, Zuo Y, Wang D and Li W:
Emerging roles of circular RNAs in tuberculosis. Front Immunol.
13:9957012022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suciu TS, Feștilă D, Berindan-Neagoe I,
Nutu A, Armencea G, Aghiorghiesei AI, Vulcan T and Băciuț M:
Circular RNA-mediated regulation of oral tissue-derived stem cell
differentiation: Implications for oral medicine and orthodontic
applications. Stem Cell Rev Rep. 20:656–671. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun Z, Dang P, Guo Y, Liu S, Hu S, Sun H,
Xu Y, Wang W, Chen C, Liu J, et al: Targeting CircAURKA prevents
colorectal cancer progression via enhancing CTNNB1 protein
degradation. Oncogene. 43:3388–3401. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun M and Yang Y: Biological functions and
applications of circRNAs-next generation of RNA-based therapy. J
Mol Cell Biol. 15:mjad0312023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Wu C, Du Y, Li Z, Li M, Hou P,
Shen Z, Chu S, Zheng J and Bai J: Expanding uncapped translation
and emerging function of circular RNA in carcinomas and
noncarcinomas. Mol Cancer. 21:132022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li K, Yang D and Liu D: Targeted
nanophotoimmunotherapy potentiates cancer treatment by enhancing
tumor immunogenicity and improving the immunosuppressive tumor
microenvironment. Bioconjug Chem. 34:283–301. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao B, Huang C, Pan J, Hu H, Liu X, Zhang
K, Zhou F, Shi X, Wu J, Yu B, et al: circPLIN2 promotes clear cell
renal cell carcinoma progression by binding IGF2BP proteins and
miR-199a-3p. Cell Death Dis. 13:10302022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang L, Li ZW, You ZH, Huang DS and Wong
L: MAGCDA: A Multi-hop attention graph neural networks method for
CircRNA-disease association prediction. IEEE J Biomed Health
Inform. 28:1752–1761. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu D and Fang L: Current research on
circular RNAs and their potential clinical implications in breast
cancer. Cancer Biol Med. 18:635–648. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ni L, Yamada T and Nakatani K: Utility of
oligonucleotide in upregulating circular RNA production in a
cellular model. Sci Rep. 14:80962024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kishore R, Garikipati VNS and Gonzalez C:
Role of circular RNAs in cardiovascular disease. J Cardiovasc
Pharmacol. 76:128–137. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cao D: Reverse complementary matches
simultaneously promote both back-splicing and exon-skipping. BMC
Genomics. 22:5862021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Saleh RO, Al-Hawary SIS, Jasim SA, Bokov
DO, Hjazi A, Oudaha KH, Alnajar MJ, Jumaa SS, Alawadi A and
Alsalamy A: A therapeutical insight into the correlation between
circRNAs and signaling pathways involved in cancer pathogenesis.
Med Oncol. 41:692024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Z and Lei X: Prediction of RBP
binding sites on circRNAs using an LSTM-based deep sequence
learning architecture. Brief Bioinform. 22:bbab3422021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang L, Lu C, Zeng M, Li Y and Wang J:
CRMSS: Predicting circRNA-RBP binding sites based on multi-scale
characterizing sequence and structure features. Brief Bioinform.
24:bbac5302023. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen Z, Chen H, Yang L, Li X and Wang Z:
CircPLCE1 facilitates the malignant progression of colorectal
cancer by repressing the SRSF2-dependent PLCE1 pre-RNA splicing. J
Cell Mol Med. 25:7244–7256. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jia Z, An J, Liu Z and Zhang F: Non-coding
RNAs in colorectal cancer: Their functions and mechanisms. Front
Oncol. 12:7830792022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fu Y and Sun H: Biogenesis, cellular
effects, and biomarker value of circHIPK3. Cancer Cell Int.
21:2562021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dal Molin A, Gaffo E, Difilippo V, Buratin
A, Tretti Parenzan C, Bresolin S and Bortoluzzi S: CRAFT: A
bioinformatics software for custom prediction of circular RNA
functions. Brief Bioinform. 23:bbab6012022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang X, Song H, Fang L and Wu T:
EIF4A3-mediated circPRKCI expression promotes triple-negative
breast cancer progression by regulating WBP2 and PI3K/AKT signaling
pathway. Cell Death Discov. 8:922022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu C, Wang S, Cao T, Huang T, Xu L, Wang
J, Li Q, Wang Y, Qian L, Xu L, et al: Newly discovered mechanisms
that mediate tumorigenesis and tumour progression: circRNA-encoded
proteins. J Cell Mol Med. 27:1609–1620. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Meng E, Deng J, Jiang R and Wu H:
CircRNA-encoded peptides or proteins as new players in digestive
system neoplasms. Front Oncol. 12:9441592022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ning Q, Jin Q, Zhao L, Wang Y, Wang J,
Yang L, Han Y, Zhi Q, Zheng J, Chen F and Dong D:
Transcriptome-scale analysis of functional alternative
back-splicing events in colorectal cancer. J Transl Med.
23:4682025. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
An S, Cui J, Yang W, Zhang M, Yu H, Lu J,
Tian Y, Qiao L, Wang X, Bao L and Zhao P: HAS-CIRCpedia-5280
Sponges miR-4712-5p inhibited colon cancer autophagyinduced by
human beta-defensin-1. J Transl Med. 23:2812025. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li Z, Zhang H, Chen Z, Wu G, Guo W and Li
Y: MicroRNA-21: A potential therapeutic target in lung cancer
(Review). Int J Oncol. 67:672025. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mao L, Yang H, Huang N, Li Y, Sang Y and
Zeng C: MiR-122 promotes metastasis of hepatoma cells by modulating
RBM47-integrin alpha V-TGF-beta signaling. PLoS One.
20:e03279152025. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bin JF, Chen LF, Wang Y, Ge H and Chen W:
Bibliometric and visual analysis of global crc circular RNA
research 2015–2023. Front Immunol. 16:15804052025. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang LT, Zhou Y, Wang T, Chen B, Cai Z,
Wang S and Tong G: Hsa_circ_0002238 promotes the malignant behavior
of colorectal cancer. Front Pharmacol. 16:15418202025. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Gao Q, Cheng X and Gao X: Circ_0089761
accelerates colorectal cancer metastasis and immune escape via
miR-27b-3p/PD-L1 axis. Physiol Rep. 12:e701372024. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lin C, Li H, Gao H, Zheng S, Wang Y, Wang
Y, Chen Y, Zhu Z, Xia P, Shi H and Han A: Hsa_circ_0004194
suppresses colorectal cancer progression via hsa-miR-27a-3p.
Heliyon. 10:e395492024. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Gao Y, Li C, Ji T, Yu K and Gao X: The
biological function and mechanism of action of circRNA as a
potential target in colorectal cancer. Crit Rev Oncol Hematol.
213:1048282025. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang Y, Luo J, Yang W and Ye WC: CircRNAs
in colorectal cancer: Potential biomarkers and therapeutic targets.
Cell Death Dis. 14:3532023. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yang J, Fan Q, Wang Y, Liu Y, Xu X, Liang
Y, Xie J, Li J, Ai F, Cao Y, et al: CircRNAs in colorectal cancer:
Potential roles, clinical applications, and natural product-based
regulation. Front Oncol. 15:15257792025. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hussen BM, Abdullah SR, Jaafar RM, Rasul
MF, Aroutiounian R, Harutyunyan T, Liehr T, Samsami M and Taheri M:
Circular RNAs as key regulators in cancer hallmarks: New progress
and therapeutic opportunities. Crit Rev Oncol Hematol.
207:1046122025. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hussain MS, Jakhmola V, Sultana A, Bisht
AS and Khan G: Potential of circular RNAs (circRNAs) neoantigen
vaccines in tumor immunotherapy. Curr Protein Pept Sci. May
26–2025.(Epub ahead of print). doi:
10.2174/0113892037389566250515094946. View Article : Google Scholar
|
|
58
|
Meng X, Xiao W, Sun J, Li W, Yuan H, Yu T,
Zhang X and Dong W: CircPTK2/PABPC1/SETDB1 axis promotes
EMT-mediated tumor metastasis and gemcitabine resistance in bladder
cancer. Cancer Lett. 554:2160232023. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zheng L, Liang H, Zhang Q, Shen Z, Sun Y,
Zhao X, Gong J, Hou Z, Jiang K, Wang Q, et al: circPTEN1, a
circular RNA generated from PTEN, suppresses cancer progression
through inhibition of TGF-β/Smad signaling. Mol Cancer. 21:412022.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yan Y, Su M and Qin B: CircHIPK3 promotes
colorectal cancer cells proliferation and metastasis via modulating
of miR-1207-5p/FMNL2 signal. Biochem Biophys Res Commun.
524:839–846. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Shafaghat Z, Radmehr S, Saharkhiz S,
Khosrozadeh A, Feiz K, Alkhathami AG, Taheripak G, Ramezani Farani
M, Rahmati R, Zarimeidani F, et al: Circular RNA, A molecule with
potential chemistry and applications in RNA-based cancer
therapeutics: An insight into recent advances. Top Curr Chem
(Cham). 383:212025. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cui YB, Wang LJ, Xu JH, Nan HJ, Yang PY,
Niu JW, Shi MY and Bai YL: Recent progress of CircRNAs in
hematological malignancies. Int J Med Sci. 21:2544–2561. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Bonizzato A, Gaffo E, Te Kronnie G and
Bortoluzzi S: CircRNAs in hematopoiesis and hematological
malignancies. Blood Cancer J. 6:e4832016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Xiao MS and Wilusz JE: Purification of
circular RNAs Using Poly(A) tailing followed by RNase R digestion.
Methods Mol Biol. 2765:3–19. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Fuchs S, Babin L, Andraos E, Bessiere C,
Willier S, Schulte JH, Gaspin C and Meggetto F: Generation of
full-length circular RNA libraries for Oxford Nanopore long-read
sequencing. PLoS One. 17:e02732532022. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wei X, Shi Y, Dai Z, Wang P, Meng X and
Yin B: Underlying metastasis mechanism and clinical application of
exosomal circular RNA in tumors (Review). Int J Oncol. 58:289–297.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Naeli P, Pourhanifeh MH, Karimzadeh MR,
Shabaninejad Z, Movahedpour A, Tarrahimofrad H, Mirzaei HR, Bafrani
HH, Savardashtaki A, Mirzaei H and Hamblin MR: Circular RNAs and
gastrointestinal cancers: Epigenetic regulators with a prognostic
and therapeutic role. Crit Rev Oncol Hematol. 145:1028542020.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Xu H, Liu Y, Cheng P, Wang C, Liu Y, Zhou
W, Xu Y and Ji G: CircRNA_0000392 promotes colorectal cancer
progression through the miR-193a-5p/PIK3R3/AKT axis. J Exp Clin
Cancer Res. 39:2832020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhou T, Xie X, Li M, Shi J, Zhou JJ, Knox
KS, Wang T, Chen Q and Gu W: Rat BodyMap transcriptomes reveal
unique circular RNA features across tissue types and developmental
stages. RNA. 24:1443–1456. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Huang YS, Jie N, Zou KJ and Weng Y:
Expression profile of circular RNAs in human gastric cancer
tissues. Mol Med Rep. 16:2469–2476. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhao B, Wang W, Ye H, Wang J, Meng K and
Yang T: A novel miRNA-based signature as predictive tool of
survival outcome of colorectal cancer patients. Chem Biol Drug
Design. 102:1024–1033. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Xiao Q, Yu H, Zhong J, Liang C, Li G, Ding
P and Luo J: An in-silico method with graph-based multi-label
learning for large-scale prediction of circRNA-disease
associations. Genomics. 112:3407–3415. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Li J, Li H, Lv X, Yang Z, Gao M, Bi Y,
Zhang Z, Wang S, Cui Z, Zhou B and Yin Z: Diagnostic performance of
circular RNAs in human cancers: A systematic review and
meta-analysis. Mol Genet Genomic Med. 7:e007492019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Wang M, Xie F, Lin J, Zhao Y, Zhang Q,
Liao Z and Wei P: Diagnostic and prognostic value of circulating
CircRNAs in cancer. Front Med. 8:6493832021. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Mohammadi D, Zafari Y, Estaki Z, Mehrabi M
and Moghbelinejad S: Evaluation of plasma circ_0006282 as a novel
diagnostic biomarker in colorectal cancer. J Clin Lab Anal.
36:e241472022. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Malviya A and Bhuyan R: Circular RNAs in
cancer: Roles, mechanisms, and therapeutic potential across
colorectal, gastric, liver, and lung carcinomas. Discover Oncol.
16:52025. View Article : Google Scholar
|
|
77
|
Ng WL, Mohd Mohidin TB and Shukla K:
Functional role of circular RNAs in cancer development and
progression. RNA Biol. 15:995–1005. 2018.PubMed/NCBI
|
|
78
|
Hussen BM, Abdullah SR, Mohammed AA, Rasul
MF, Hussein AM, Eslami S, Glassy MC and Taheri M: Advanced
strategies of targeting circular RNAs as therapeutic approaches in
colorectal cancer drug resistance. Pathol Res Pract.
260:1554022024. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhang Y, Li C, Liu X, Wang Y, Zhao R, Yang
Y, Zheng X, Zhang Y and Zhang X: circHIPK3 promotes
oxaliplatin-resistance in colorectal cancer through autophagy by
sponging miR-637. EBioMedicine. 48:277–288. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
He AT, Liu J, Li F and Yang BB: Targeting
circular RNAs as a therapeutic approach: Current strategies and
challenges. Signal Transduct Target Ther. 6:1852021. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wu X, Li Z, Cao C, Ge J, Shen X, Sun W and
Guo J and Guo J: A novel DNA binding protein encoded by circZNF131
inhibits the growth of gastric cancer by suppressing CTBP2
transcription. Int J Biol Macromol. 314:1442362025. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Zhu X, Zhang X, Qin Y, Chen Y, Feng X,
Deng S, Hu F, Yuan Y, Luo X, Du K, et al: Circular RNA circATM
binds PARP1 to suppress Wnt/β-catenin signaling and induce cell
cycle arrest in gastric cancer cells. J Adv Res. Apr 25–2025.(Epub
ahead of print). doi: 10.1016/j.jare.2025.04.033. View Article : Google Scholar
|
|
83
|
Lian QX and Song Y, Han L, Wang Z and Song
Y: Development of a circHIPK3-based ceRNA network and
identification of mRNA signature in breast cancer patients
harboring BRCA mutation. PeerJ. 11:e155722023. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
d'Angelo DM, Attanasi M, Di Donato G,
Lapergola G, Flacco M, Chiarelli F, Altobelli E and Breda L: The
role of serum calprotectin in defining disease outcomes in
non-systemic juvenile idiopathic arthritis: A pilot study. Int J
Mol Sci. 24:16712023. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Weidle UH and Nopora A: Up-regulated
circular RNAs in colorectal cancer: New entities for therapy and
tools for identification of therapeutic targets. Cancer Genomics
Proteomics. 20:132–153. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Karmacharya P, Patil BR and Kim JO: Recent
advancements in lipid-mRNA nanoparticles as a treatment option for
cancer immunotherapy. J Pharm Investig. 52:415–426. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Peng W, Xie Y, Liu Y, Xu J, Yuan F, Li C,
Qin T, Lu H, Duan C and Hu J: Targeted delivery of
CD163+ macrophage-derived small extracellular vesicles
via RGD peptides promote vascular regeneration and stabilization
after spinal cord injury. J Control Release. 361:750–765. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Okholm TLH, Kamstrup AB, Nielsen MM,
Hollensen AK, Graversgaard ML, Sørensen MH, Kristensen LS, Vang S,
Park SS, Yeo E, et al: circHIPK3 nucleates IGF2BP2 and functions as
a competing endogenous RNA. eLife. 13:RP917832024. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Jadhav V, Vaishnaw A, Fitzgerald K and
Maier MA: RNA interference in the era of nucleic acid therapeutics.
Nat Biotechnol. 42:394–405. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Qiu S, Adema CM and Lane T: A
computational study of off-target effects of RNA interference.
Nucleic Acids Res. 33:1834–1847. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Tang Q and Khvorova A: RNAi-based drug
design: Considerations and future directions. Nat Rev Drug Discov.
23:341–364. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
He J, Biswas R, Bugde P, Li J, Liu DX and
Li Y: Application of CRISPR-Cas9 system to study biological
barriers to drug delivery. Pharmaceutics. 14:8942022. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Wang SW, Gao C, Zheng YM, Yi L, Lu JC,
Huang XY, Cai JB, Zhang PF, Cui YH and Ke AW: Current applications
and future perspective of CRISPR/Cas9 gene editing in cancer. Mol
Cancer. 21:572022. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Schlicher L, Green LG, Romagnani A and
Renner F: Small molecule inhibitors for cancer immunotherapy and
associated biomarkers-the current status. Front Immunol.
14:12971752023. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Yamaguchi H, Hsu JM, Yang WH and Hung MC:
Mechanisms regulating PD-L1 expression in cancers and associated
opportunities for novel small-molecule therapeutics. Nat Rev Clin
Oncol. 19:287–305. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Winkle M, El-Daly SM, Fabbri M and Calin
GA: Noncoding RNA therapeutics-challenges and potential solutions.
Nat Rev Drug Discov. 20:629–651. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zhang H, Wu Y, Hu Y, Li X, Zhao M and Lv
Z: Targeted nanoparticle drug delivery system for the enhancement
of cancer immunotherapy. J Biomed Nanotechnol. 15:1839–1866. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Mainini F and Eccles MR: Lipid and
polymer-based nanoparticle siRNA delivery systems for cancer
therapy. Molecules. 25:26922020. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Tang L, Mei Y, Shen Y, He S, Xiao Q, Yin
Y, Xu Y, Shao J, Wang W and Cai Z: Nanoparticle-mediated targeted
drug delivery to remodel tumor microenvironment for cancer therapy.
Int J Nanomedicine. 16:5811–5829. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Chen L, Wang C, Sun H, Wang J, Liang Y,
Wang Y and Wong G: The bioinformatics toolbox for circRNA discovery
and analysis. Brief Bioinform. 22:1706–1728. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Chander S, Bhatt S, Dua K and Jadhav H:
Editorial: Recent trends and spotlight on nucleotide-based drugs:
Novel targets, their design, delivery, and clinical potential.
Front Pharmacol. 14:12458092023. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Lin J, Lyu Z, Feng H, Xie H, Peng J, Zhang
W, Zheng J, Zheng J, Pan Z, Li Y, et al: CircPDIA3/miR-449a/XBP1
feedback loop curbs pyroptosis by inhibiting palmitoylation of the
GSDME-C domain to induce chemoresistance of colorectal cancer. Drug
Resist Updat. 76:1010972024. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Zhou Y, Gao Y, Peng Y, Cai C, Han Y, Chen
Y, Deng G, Ouyang Y, Shen H, Zeng S, et al: QKI-induced
circ_0001766 inhibits colorectal cancer progression and rapamycin
resistance by miR-1203/PPP1R3C/mTOR/Myc axis. Cell Death Discov.
11:1922025. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Molaei P, Mahdavinezhad A, Najafi R,
Hashemi M, Tapak L and Afshar S: Role of hsa_Circ_0001821 in
colorectal cancer pathogenesis and response to 5-fluorouracil
through miR-203a-3p/FGF-2 Axis. Iran Biomed J. 29:82–89.
2025.PubMed/NCBI
|
|
105
|
Prajapati RN, Bhushan B, Singh K, Chopra
H, Kumar S, Agrawal M, Pathak D and Chanchal DK: Laxmikant: Recent
advances in pharmaceutical design: Unleashing the potential of
novel therapeutics. Curr Pharm Biotechnol. 25:2060–2077. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Ratajczak K, Grel H, Olejnik P, Jakiela S
and Stobiecka M: Current progress, strategy, and prospects of
PD-1/PDL-1 immune checkpoint biosensing platforms for cancer
diagnostics, therapy monitoring, and drug screening. Biosens
Bioelectron. 240:1156442023. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Wu W, Zhao F and Zhang J: circAtlas 3.0: A
gateway to 3 million curated vertebrate circular RNAs based on a
standardized nomenclature scheme. Nucleic Acids Res. 52:D52–D60.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Hu D, Zhang P and Chen M: Database
resources for functional circular RNAs. Methods Mol Biol.
2284:457–466. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Shen W, Song Z, Zhong X, Huang M, Shen D,
Gao P, Qian X, Wang M, He X, Wang T, et al: Sangerbox: A
comprehensive, interaction-friendly clinical bioinformatics
analysis platform. Imeta. 1:e362022. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Wu W, Ji P and Zhao F: CircAtlas: An
integrated resource of one million highly accurate circular RNAs
from 1070 vertebrate transcriptomes. Genome Biol. 21:1012020.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Chaabane M, Andreeva K, Hwang JY, Kook TL,
Park JW and Cooper NGF: seekCRIT: Detecting and characterizing
differentially expressed circular RNAs using high-throughput
sequencing data. PLoS Comput Biol. 16:e10083382020. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Hou L, Zhang J and Zhao F: Full-length
circular RNA profiling by nanopore sequencing with CIRI-long. Nat
Protoc. 18:1795–1813. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Li X, Chen B, Xu Y, Zhou A and Wu B:
Identification of potential diagnostic biomarkers and immune
infiltration features in diabetic foot ulcer by bioinformatics
analysis and validation. Cell Mol Biol (Noisy-le-Grand).
69:180–188. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Zhu Y, Cao F, Liu F, Liu S, Meng L, Gu L,
Zhao H, Sang M and Shan B: Identification of potential circular RNA
biomarkers in lung adenocarcinoma: A bioinformatics analysis and
retrospective clinical study. Oncol Lett. 23:1442022. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Song H, Sun J, Kong W, Ji Y, Xu D and Wang
J: Construction of a circRNA-related ceRNA prognostic regulatory
network in breast cancer. Onco Targets Ther. 13:8347–8358. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Kohansal M, Alghanimi YK, Banoon SR,
Ghasemian A, Afkhami H, Daraei A, Wang Z, Nekouian N, Xie J, Deng X
and Tang H: CircRNA-associated ceRNA regulatory networks as
emerging mechanisms governing the development and
biophysiopathology of epilepsy. CNS Neurosci Ther. 30:e147352024.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Humphreys DT, Fossat N, Demuth M, Tam PPL
and Ho JWK: Ularcirc: Visualization and enhanced analysis of
circular RNAs via back and canonical forward splicing. Nucleic
Acids Res. 47:e1232019. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Zhong S and Feng J: CircPrimer 2.0: A
Software for annotating circRNAs and predicting translation
potential of circRNAs. BMC Bioinformatics. 23:2152022. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Sharko F, Rbbani G, Siriyappagouder P,
Raeymaekers JAM, Galindo-Villegas J, Nedoluzhko A and Fernandes
JMO: CircPrime: A web-based platform for design of specific
circular RNA primers. BMC Bioinformatics. 24:2052023. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Gao Y, Zhang J and Zhao F: Circular RNA
identification based on multiple seed matching. Brief Bioinform.
19:803–810. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Glažar P, Papavasileiou P and Rajewsky N:
circBase: A database for circular RNAs. RNA. 20:1666–1670. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Meng X, Hu D, Zhang P, Chen Q and Chen M:
CircFunBase: A database for functional circular RNAs. Database
(Oxford). 2019:baz0032019. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Fan C, Lei X, Tie J, Zhang Y, Wu FX and
Pan Y: CircR2Disease v2.0: An updated web server for experimentally
validated circRNA-disease associations and its application.
Genomics Proteomics Bioinformatics. 20:435–445. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Sun ZY, Yang CL, Huang LJ, Mo ZC, Zhang
KN, Fan WH, Wang KY, Wu F, Wang JG, Meng FL, et al: circRNADisease
v2.0: An updated resource for high-quality experimentally supported
circRNA-disease associations. Nucleic Acids Res. 52:D1193–D1200.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Yuan L, Zhao J, Shen Z, Zhang Q, Geng Y,
Zheng CH and Huang DS: iCircDA-NEAE: Accelerated attribute network
embedding and dynamic convolutional autoencoder for circRNA-disease
associations prediction. PLoS Comput Biol. 19:e10113442023.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Fan C, Lei X, Fang Z, Jiang Q and Wu FX:
CircR2Disease: A manually curated database for experimentally
supported circular RNAs associated with various diseases. Database
(Oxford). 2018:bay0442018. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Sharma AR, Banerjee S, Bhattacharya M,
Saha A, Lee SS and Chakraborty C: Recent progress of circular RNAs
in different types of human cancer: Technological landscape,
clinical opportunities and challenges (Review). Int J Oncol.
60:562022. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Utley D, Edwards B, Budnick A, Grotewold E
and Sederoff H: Camelina circRNA landscape: Implications for gene
regulation and fatty acid metabolism. Plant Genome. 18:e205372025.
View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Huang Z, Su R, Qing C, Peng Y, Luo Q and
Li J: Plasma circular RNAs hsa_circ_0001953 and hsa_circ_0009024 as
diagnostic biomarkers for active tuberculosis. Front Microbiol.
9:20102018. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Wu K, Tan J and Yang C: Recent advances
and application value of circRNA in neuroblastoma. Front Oncol.
13:11803002023. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Drula R, Braicu C and Neagoe IB: Current
advances in circular RNA detection and investigation methods: Are
we running in circles? Wiley Interdiscip Rev RNA. 15:e18502024.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Chen I, Chen CY and Chuang TJ: Biogenesis,
identification, and function of exonic circular RNAs. Wiley
Interdiscip Rev RNA. 6:563–579. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Szabo L and Salzman J: Detecting circular
RNAs: Bioinformatic and experimental challenges. Nat Rev Genet.
17:679–692. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Farina FM, Weber C and Santovito D: The
emerging landscape of non-conventional RNA functions in
atherosclerosis. Atherosclerosis. 374:74–86. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Wang Y, Li S, Wang X, Chen Q, He Z, Luo C
and Sun J: Smart transformable nanomedicines for cancer therapy.
Biomaterials. 271:1207372021. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Kim T, Nam K, Kim YM, Yang K and Roh YH:
DNA-assisted smart nanocarriers: Progress, challenges, and
opportunities. ACS Nano. 15:1942–1951. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
He L, Man C, Xiang S, Yao L, Wang X and
Fan Y: Circular RNAs' cap-independent translation protein and its
roles in carcinomas. Mol Cancer. 20:1192021. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Martins DC, Babajide O, Maani N, Abdalla
SM, Gómez EJ, Pongsiri MJ, Tlou S, Leung GM, Benjamin GC, Goosby E,
et al: Integrating social determinants in Decision-making processes
for health: Insights from conceptual Frameworks-the 3-D commission.
J Urban Health. 98:51–59. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Drula R, Pirlog R, Trif M, Slaby O, Braicu
C and Berindan-Neagoe I: circFOXO3: Going around the mechanistic
networks in cancer by interfering with miRNAs regulatory networks.
Biochim Biophys Acta Mol Basis Dis. 1867:1660452021. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Shoda K, Kuwano Y, Ichikawa D and Masuda
K: circRNA: A new biomarker and therapeutic target for esophageal
cancer. Biomedicines. 10:16432022. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Fang L, Velema WA, Lee Y, Xiao L, Mohsen
MG, Kietrys AM and Kool ET: Pervasive transcriptome interactions of
protein-targeted drugs. Nat Chem. 15:1374–1383. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Long F, Lin Z, Li L, Ma M, Lu Z, Jing L,
Li X and Lin C: Comprehensive landscape and future perspectives of
circular RNAs in colorectal cancer. Mol Cancer. 20:262021.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Mao J and Lu Y: Roles of circRNAs in the
progression of colorectal cancer: Novel strategies for detection
and therapy. Cancer Gene Ther. 31:831–841. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Costa MC, Calderon-Dominguez M, Mangas A,
Campuzano O, Sarquella-Brugada G, Ramos M, Quezada-Feijoo M,
Pinilla JMG, Robles-Mezcua A, Del Aguila Pacheco-Cruz G, et al:
Circulating circRNA as biomarkers for dilated cardiomyopathy
etiology. J Mol Med (Berl). 99:1711–1725. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Wang W, Wang Y, Piao H, Li B, Huang M, Zhu
Z, Li D, Wang T, Xu R and Liu K: Circular RNAs as potential
biomarkers and therapeutics for cardiovascular disease. PeerJ.
7:e68312019. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Weidle UH and Birzele F: Deregulated
circRNAs in epithelial ovarian cancer with activity in preclinical
in vivo models: Identification of targets and new modalities for
therapeutic intervention. Cancer Genomics Proteomics. 21:213–237.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Wen G, Zhou T and Gu W: The potential of
using blood circular RNA as liquid biopsy biomarker for human
diseases. Protein Cell. 12:911–946. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Xu S, Zhou L, Ponnusamy M, Zhang L, Dong
Y, Zhang Y, Wang Q, Liu J and Wang K: A comprehensive review of
circRNA: From purification and identification to disease marker
potential. PeerJ. 6:e55032018. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Giorgioni L, Ambrosone A, Cometa MF,
Salvati AL, Nisticò R and Magrelli A: Revolutionizing CAR T-cell
therapies: Innovations in genetic engineering and manufacturing to
enhance efficacy and accessibility. Int J Mol Sci. 25:103652024.
View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Rocchi S, Scherer E, White PL, Guitton A,
Alanio A, Botterel F, Bougnoux ME, Buitrago MJ, Cogliati M, Cornu
M, et al: Interlaboratory assays from the fungal PCR initiative and
the Modimucor Study Group to improve qPCR detection of Mucorales
DNA in serum: One more step toward standardization. J Clin
Microbiol. 63:e01525242025. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Pisignano G, Michael DC, Visal TH, Pirlog
R, Ladomery M and Calin GA: Going circular: History, present, and
future of circRNAs in cancer. Oncogene. 42:2783–2800. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Zhang J, Hou L, Zuo Z, Ji P, Zhang X, Xue
Y and Zhao F: Comprehensive profiling of circular RNAs with
nanopore sequencing and CIRI-long. Nat Biotechnol. 39:836–845.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Kulkarni SR, Dieterich C and Jakobi T:
Extending scope and power of circular RNA research with circtools
2.0. bioRxiv. Feb 19–2025.(Epub ahead of print). doi:
10.1101/2025.02.16.638209.
|
|
154
|
Bustin SA, Ruijter JM, van den Hoff MJB,
Kubista M, Pfaffl MW, Shipley GL, Tran N, Rödiger S, Untergasser A,
Mueller R, et al: MIQE 2.0: Revision of the minimum information for
publication of quantitative Real-time PCR experiments guidelines.
Clin Chem. Apr 24–2025.(Epub ahead of print). doi:
10.1093/clinchem/hvaf043. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Nielsen AF, Bindereif A, Bozzoni I, Hanan
M, Hansen TB, Irimia M, Kadener S, Kristensen LS, Legnini I,
Morlando M, et al: Best practice standards for circular RNA
research. Nat Methods. 19:1208–1220. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Wilson DB, Steinman L and Gold DP: The
V-region disease hypothesis: New evidence suggests it is probably
wrong. Immunol Today. 14:376–382. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Sun Z, Xu Y, Si C, Wu X, Guo Y, Chen C and
Wang C: Targeting m7G-enriched circKDM1A prevents colorectal cancer
progression. Mol Cancer. 23:1792024. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Chen RX, Xu SD, Deng MH, Hao SH, Chen JW,
Ma XD, Zhuang WT, Cao JH, Lv YR, Lin JL, et al: Mex-3 RNA binding
family member A (MEX3A)/circMPP6 complex promotes colorectal cancer
progression by inhibiting autophagy. Signal Transduct Target Ther.
9:802024. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Xie J, Xie Y, Tan W, Ye Y, Ou X, Zou X, He
Z, Wu J, Deng X, Tang H, et al: Deciphering the role of ELAVL1:
Insights from pan-cancer multiomics analyses with emphasis on
nasopharyngeal carcinoma. J Transl Int Med. 13:138–155. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Gao Y, Li B, Jin Y, Cheng J, Tian W, Ying
L, Hong L, Xin S, Lin B, Liu C, et al: Spatial multi-omics
profiling of breast cancer oligo-recurrent lung metastasis.
Oncogene. 44:2268–2282. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Li S, Wang J, Qiu L, Fu G, Li Y, Su Q, Zhu
Y, Zhao F, Tian J, Huang J, et al: Comprehensive circular RNA
profiling provides insight into colorectal cancer pathogenesis and
reveals diagnostically relevant biomarkers. Clin Transl Med.
14:e700492024. View Article : Google Scholar : PubMed/NCBI
|
